Na Yang

机构：China Pharmaceutical University, Xuzhou Medical College, Nanjing Drum Tower Hospital, Chongqing Medical University · ORCID：0000-0002-5033-0978

发表论文 44 篇 · 总被引 693 次 · h-index 11

代表论文

• Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases (2022 · JAMA Internal Medicine · 被引 318)
• Microsatellite instability and Epstein-Barr virus combined with PD-L1 could serve as a potential strategy for predicting the prognosis and efficacy of postoperative chemotherapy in gastric cancer (2021 · PeerJ · 被引 20)
• Development and validation of a machine learning–based model for varices screening in compensated cirrhosis (CHESS2001): an international multicenter study (2022 · Gastrointestinal Endoscopy · 被引 19)
• Tissue inhibitor of metalloproteinase-1 (TIMP-1) as a prognostic biomarker in gastrointestinal cancer: a meta-analysis (2021 · PeerJ · 被引 10)
• Improvements in airflow characteristics and effect on the NOSE score after septoturbinoplasty: A computational fluid dynamics analysis (2022 · PLoS ONE · 被引 9)
• A novel inflammation-related prognostic model for predicting the overall survival of primary central nervous system lymphoma: A real-world data analysis (2023 · Frontiers in Oncology · 被引 7)